These Analysts Slash Their Forecasts On Constellation Brands Following Q2 Results
Constellation Brands (STZ) reported Q2 earnings of $3.74 per share, beating estimates. Sales were $2.633 billion, also exceeding expectations. The company raised fiscal 2027 GAAP EPS guidance to $11.85-$12.55 and acquired SpikedAde. Shares fell 1% in pre-market trading. Analysts adjusted price targets, with HSBC downgrading to Hold and cutting its target to $135.
How this was made
The 30-second read
Why it matters
Earnings beat was offset by analyst target cuts, leading to a modest pre‑market decline.
Market read
The earnings beat and guidance raise are partially offset by analyst downgrades, creating a mixed short‑term outlook for STZ.
What to watch
SpikedAde acquisition may unlock growth in the RTD segment, not fully reflected in current price targets.
Background
Constellation Brands (STZ) is a leading beer, wine, and spirits producer. The Q2 report includes EPS of $3.74 vs $3.56 estimate and sales of $2.633 bn vs $2.542 bn estimate.
Ticker impact
Constellation Brands reported Q2 earnings beat, raised FY2027 EPS guidance, and analysts cut price targets, causing a 1% pre‑market decline.
likely pressure as the market prices in lower price targets and the downgrade to Hold.
Guidance raise is modest and analysts reduced targets, indicating limited upside and potential further sell‑off.
Market effects
Beverage alcohol sector may see modest re‑rating as peers' guidance and analyst sentiment shift.
U.S. consumer discretionary stocks could face slight pressure.
Limited; impact confined to Constellation and its immediate peers.
Counterpoint
The earnings beat and guidance raise could support a short‑term bounce if the market overreacts to downgrades.
Key entities
- companyConstellation Brands
Issuer of the earnings report.
- analyst_firmHSBC
Downgraded STZ to Hold and cut target to $135.
- analyst_firmMorgan Stanley
Maintained rating, cut target to $145.
- analyst_firmNeedham
Maintained Buy, cut target to $150.
